Gait Disorders Clinical Trial
— RACEOfficial title:
Randomized ActiveStep Comparative Effectiveness Trial
Verified date | July 2018 |
Source | Dartmouth-Hitchcock Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators are conducting a multi-center randomized prospective trial comparing a
standard physical therapy gait and balance program with a gait and balance program that
includes the ActiveStep™ treadmill.
Subjects will be randomized to either have the ActiveStep™ as part of their therapy or to
have their therapy without it. Data will be gathered from session notes, medical records and
short interviews with the subjects at baseline and every 3 months over the telephone for the
duration of the study.
Status | Completed |
Enrollment | 506 |
Est. completion date | August 2016 |
Est. primary completion date | July 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility |
Inclusion Criteria: - Age 65 and over - Referred to physical therapy for balance training Exclusion Criteria: - Age < 65 - Unable to use treadmill - Severe vertigo - Not a candidate for gait/balance PT - Not competent to consent to research |
Country | Name | City | State |
---|---|---|---|
United States | Concord Hospital Rehabilitation Services | Epsom | New Hampshire |
United States | Cheshire Medical Center - Farnum Rehabilitation Center | Keene | New Hampshire |
United States | Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire |
United States | The Elliot Hospital | Manchester | New Hampshire |
United States | Newton-Wellesley Hospital | Newton | Massachusetts |
United States | South Shore Neurological Associates | Patchogue | New York |
United States | Spaulding Rehabilitation Hospital | Salem | Massachusetts |
United States | White River Junction Veterans Administration Medical Center | White River Junction | Vermont |
Lead Sponsor | Collaborator |
---|---|
Jon D. Lurie | Agency for Healthcare Research and Quality (AHRQ) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Subjects Reporting Any Fall | 3 months | ||
Primary | Number of Subjects Reporting a Fall-related Injury | 3 months | ||
Secondary | Change in Timed Up and Go From Baseline | End of Treatment | ||
Secondary | Change in Berg Balance Scale From Baseline | The Berg Balance Measure (Berg) was designed to test an elderly patient's level of balance. The test consists of 14 balance items that have been deemed safe for elderly patients to perform. The Berg is a task performance exam that takes about 15 to 20 minutes to complete. The test is scored while it is administered. Each of the independent items are scored on a five point ordinal scale where 0 indicates the patient's inability to perform the task and 4 represents independence; the individual points are then summed to achieve a total score (range 0 - 56). The higher the patient's score on the Berg the more independent the patient. The reported outcome is the change in the Berg between baseline and end of treatment. | End of Treatment | |
Secondary | Change in Dynamic Gait Index From Baseline | The Dynamic Gait Index (DGI) is another instrument that was developed to assess the likelihood of falling in older adults and tests eight facets of gait. The DGI takes about 15 minutes and requires the following equipment: a Box (Shoebox); 2 Cones; Stairs; and a 20' walkway that is 15" wide. Each item is scored on a four-point ordinal scale, ranging from 0-3 where "0" indicates the lowest level of function and "3" the highest level of function, resulting in a total score of 0 to 24. The interpretation guidelines state that a score < 19/24 is predictive of falls in the elderly while as score of > 22/24 indicate safe walkers. The outcome reported is the change in the DGI between baseline and end-of-treatment. | End of Treatment | |
Secondary | Change in Activities-specific Balance Confidence From Baseline | The Activity-specific Balance Confidence scale (ABC) is a patient self-report measure tthat measures the subject's self-assessed confidence in being able to perform 16 specific activities without losing their balance or becoming unsteady. For each task (i.e. walking around the house, sweeping the floor, walking outside on an icy sidewalk) the subject indicates their level of confidence in doing the activity without losing their balance. For items the subject does not normally perform, they are asked to try and imagine how confident they would feel if they had to do the activity. For subjects who normally use a walking aid to do the specific activity, they are asked to rate their confidence as if they were using these supports. Each item is rated 0-100 for each item. To obtain the final score, the ratings are averaged across the 16 items to produce an overall score from 0-100 with higher scores indicated greater balance confidence. | End of Treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00768378 -
Safety and Efficacy Study of BrainPort® Balance Device in Peripheral Vestibular Dysfunction.
|
N/A | |
Completed |
NCT02134158 -
Impact of tDCS on Locomotion and Equilibrium in Hemiplegic Patients
|
Phase 4 | |
Not yet recruiting |
NCT06453863 -
Effects of Biofeedback Footwear in Parkinson's Disease: Assessment of Functional Motor Abilities and Locomotion
|
N/A |